Market Report Source

Overview

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments.

Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses.

The disposable syringe market segments are identified as:
1) total reusable needle and syringe market;
2) total disposable needle and syringe market;
3) prefilled syringes;
4) safety syringes;
5) insulin injector pens;
6) needleless injectors;
7) vaccination injectors;
8) blood collection needles and syringes;
9) hypodermic needles and syringes market;
10) insulin needles and syringes market;
11) specialty needles and syringes market; and
12) needleless injector market.

Table of Contents

1. Introduction
1.1 Statement of Report
1.2 About This Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary

2. Disposable Syringe Markets
2.1 Overview
2.2 Infection Control and Safety
2.3 Hospital Consolidations Pressure Companies to Reduce Prices
2.4 Needleless Injector Manufacturers Forge Strategic Alliances
2.5 Technological Advancements in Disposable Syringes

3. Syringe Market Segments
3.1 Overview
3.1.1 World Market
3.1.2 U.S. Market
3.2 Total Reusable Needle and Syringe Market
3.3 Total Disposable Needle and Syringe Market
3.3.1 Drivers of Safety Syringes
3.3.2 Restraints to Safety Syringes
3.4 Pre-filled Syringes
3.5 Insulin Injector Pens
3.6 Needleless Injectors
3.7 Vaccination Injectors
3.8 Needle and Syringe Market Trends
3.8.1 Market Segments
3.8.2 Customer Needs
3.8.3 Competitor Analysis
3.8.4 Target Markets for Specialty Syringes
3.8.5 Third Party Reimbursement
3.8.6 Regulation
3.8.7 Drug Discovery Trends
3.8.8 Demographic Shifts
3.8.9 Managed Care Initiatives
3.8.10 Growth in Home Healthcare

4. Technology Development and Sterilization Methods
4.1 Disposable Syringes
4.1.1 Autodestruct Syringes
4.1.2 SoloShot™
4.2 Monodose Syringes
4.3 Pre-filled Syringes
4.3.1 Features of Pre-filled Membrane Syringes
4.3.1.1 Products in Pre-filled Syringes
4.3.1.2 Compatibility of Drug Components
4.3.1.3 Lyophilized Drugs and Powders
4.3.1.4 Dual-chambered Syringes
4.3.1.5 Pre-filled Diluent Syringes
4.3.1.6 Needle Safety Devices for Pre-filled Syringes
4.3.1.7 Sterility Maintenance
4.3.2 Pen Syringes
4.3.2.1 Technical Advances in Pens
4.3.2.2 Advantages of Pens
4.3.2.3 Pen Types and Styles
4.3.2.4 Pre-filled Pens
4.3.2.5 Reusable Pens
4.3.2.6 Device Preparation
4.3.2.7 Autopen
4.3.2.8 Unifine Pentips
4.3.3 Autoject 2
4.4 Insulin Syringes
4.5 Jet Injectors
4.6 Insulin Pens
4.7 Uniject™ Injection Device
4.8 Microneedle
4.9 Needle Free Injection
4.9.1 Hypospray
4.10 Glass Pre-fillable Syringes
4.11 Retractable Syringe
4.12 Ultrasafe Passive Delivery Systems
4.13 Ultrasmall Syringes and Microsyringes
4.14 Tip Lok® Syringes
4.15 Product Profiles
4.15.1 Gettig Guard™
4.15.2 Inviro SNAP! ®
4.15.3 Maxxon Safety Syringe
4.15.4 Monoject Magellan™
4.15.5 Needle-Pro
4.15.6 Point Lok®
4.15.7 SafetyGlide™
4.16 SC Injection Technology

5. Business Trends
5.1 Market Drivers
5.2 Market Prospects
5.3 Marketing and Distribution
5.4 Competitive Landscape
5.5 Business Developments
5.6 Acquisitions and Partnerships
5.7 Key Players
5.7.1 Kendall
5.7.2 Becton Dickinson
5.7.3 C.R. Bard
5.7.4 International Medication Systems
5.7.5 Terumo Medical Corporation

6. Future Technologies
6.1 Thermostable Vaccines and Vaccine Vial Monitors
6.2 Sugar Glass
6.3 Issues in Technology Transfer for AD Syringes

7. Regulatory Measures
7.1 Safety Syringes in Europe
7.2 Safety Syringe Regulations and Recommendations
7.3 Reimbursement Outlook for Injectables

8. Corporate Profiles

Appendix 1: FDA Approved Syringe Manufacturers
Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List
Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing
Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act

INDEX OF FIGURES

Figure 3.1: U.S. Safety Needle and Syringe Market
Figure 6.1: Strategy of the “Sugar Project”

INDEX OF TABLES

Table 2.1: Global Market for Needles and Syringes, 2001-2010
Table 3.1: Global Market for Injection Devices by Category
Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010
Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010
Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010
Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006
Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region
Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006
Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006
Table 3.9: Share of Worldwide Safety Syringes Market by Competitor
Table 3.10: Share of Worldwide Market for Safety Syringes by Region
Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010
Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006
Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor
Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region
Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006
Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005
Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006
Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006
Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region
Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006
Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor
Table 3.22: Summary of Strengths and Weaknesses of Available Syringes
Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004
Table 4.1: Injection Data Using Soloshot and Disposable Syringes
Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes
Table 4.3: Wastage Analysis (Per Vial Used)
Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices
Table 4.5: Region-wise Market of Pre-filled Syringes
Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006
Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004
Table 4.8: Insulin Delivery Systems Percent Retail Market Share
Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company
Table 4.10: Commonly-Available Insulin Syringes
Table 4.11: Features of Available Insulin Pumps
Table 4.12: Features of Available Jet Injectors
Table 4.13: Currently Available Insulin Delivery Pens
Table 4.14: Summary of Clinical and Field Experience with the Uniject Device